Lyme's desease Bibliographic review
Main Article Content
Abstract
The Lyme disease or Borreliosis consist in one of the most frecuent zoonotic diseases in the countries of the northern hemisphere, such as United States, all Europe and some zones of Asia, transmitted by the members of the family ixodidae, pejorative called ²hard-bodied ticks², its etiologic agent is the Borrelia burgdorferi, wich causes a florid clinic picture characterize by fever, fatigue, and algias, among other manifestations of attack to the general condition, but related to diverse factors, practically all the countries of the southern hemisphere has some sporadic cases. His clinical presentation is wide, that is why it was called ²the new great imitator², in reference to the syphilis, called the great imitator in the past, it makes difficult to diagnose in not endemic areas and needs a strong clinical suspicion, and demostrate the clinical findings with laboratory tests, a few months ago it was identify the first autochthonous case in our country, in the past we treated only imported cases from North America. The managment of this pathology created a intense debate among the international organizations, some claims that Lyme is a rare, well geografically defined and ambulatory treatment, others indicates that Borreliosis is a worldwide distributed disease and unpredictible behavoir, this great contradictions between them about the diagnosis and treatment produce confusion in the health personnel internacionally. About treatment, this have not change, using drugs available in all levels of attention, with the dosis used for other conditions, but with different criteria about the duration of the therapy, from a few weeks to several months according to the severity of the patient, it can be harmful depending on the prolonged exposition to antibiotics.
It is evident that an unification of the criteria is nedded, in both diagnostic and treatment of the special conditions, such as Neuroborreliosis and Lyme arthritis.
Downloads
Article Details
Los autores que publiquen en la Revista ACTA ACADÉMICA aceptan las siguientes condiciones:
De acuerdo con la legislación de derechos de autor, la Revista ACTA ACADÉMICA reconoce y respeta el derecho moral de los autores, así como la titularidad del derecho patrimonial, el cual será cedido a la revista para su difusión en acceso abierto.
La Revista ACTA ACADÉMICA no realiza cargos a las/los autoras/es por enviar y procesar artículos para su publicación.
Todos los textos publicados por la Revista ACTA ACADÉMICA –sin excepción– se distribuyen amparados bajo la licencia Creative Commons que permite a terceros utilizar lo publicado siempre que mencionen la autoría del trabajo y a la primera publicación en esta revista.
References
Aguero R., M. (2008) Lyme disease: Laboratory issues. Infect Dis Clin North Am, 22: 301-313.
Aucott, J., Morrison, C., Muñoz, B. [et al.] (2009). Diagnostic challenges of early Lyme disease: Lessons from a community case series. [Versión electrónica], BCM Infect Dis, 9: 79.
Recuperado el 6 de febrero de 2013, de http://www.ncbi.nlm. nih.gov/pmc/articles/PMC2698836/
Baker, P. (2008). Perspectives on Chronic Lyme Disease. The American Journal of Medicine, 121 (7).
Bhate, C. & Schwartz, R.A. (2011). Lyme disease. Part I. Advances and perspectives. J Am Acad Dermatol, 64: 619-36.
Bhate, C. & Schwartz, R.A. (2011). Lyme disease. Part II. Management and prevention. J Am Acad Dermatol, 64: 639-53. Boza C., R. (2011). Enfermedad de Lyme (Borreliosis de Lyme) en Costa Rica. Acta Méd Costarric., 53 (1): 34-36.
British Infection Association. (2011). The epidemiology, prevention, investigation and treatment of Lyme borreliosis in United Kingdom patients: a position statement by the British Infection Association. J Infect., 62(5), 329-38.
Bunikis, J., Garpmo, U., Taso, J., Berglund, J., Durland, F. & Barbour, A. (2004). Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe. Microbiology, 150, 1741–1755.
Burgdorfer, W., Barbour, A., Hayes, S., Benach, J. Grunwaldt, E. & Davis, J. (1982). Lyme disease-a tick-borne spirochetosis? Science, 216 (4552), 1317-9.
Cameron, D. [et al.] (2004). Evidence-based guidelines for the management of Lyme disease. Expert Rev. Anti-infect. Ther. 2 (1 Suppl): S1-13. Recuperado 06 de febrero de 2013, de http:// www.ncbi.nlm.nih.gov/pubmed/15581390
Espinoza L., F. [et al.]. (2010). Uso de la reacción en cadena de la polimerasa para Borrelia burgdorferi en lesiones de esclerodermia localizada (Morfea), en pacientes venezolanos. [Versión electrónica], Invest Clin 51 (3): 381 – 390. Recuperado el 6 de febrero de 2013, de http://www.scielo.org.ve/pdf/ic/ v51n3/art08.pdf
Fauci, A. (2012). Harrison: Principios de Medicina Interna. (18ª. ed.). México: Editorial McGraw-Hill.
Heymann, W. & Ellis, D. (2012). Borrelia burgdorferi infections in the United States. J Clin Aesth Dermatol, 5 (8), 18–28.
Hynote, E.D., Mervine P.C. & Stricker, R.B. (2012). Clinical evidence for rapid transmission of Lyme disease following a tickbite. [Versión electrónica], Diagn Microbiol Infect Dis 72, 188–192. Recuperado el 6 de febrero de 2013, de http://www. ncbi.nlm.nih.gov/pubmed/22104184
Johnson, L. & Stricker, R. (2010). The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guideline. Philosophy, ethics and Humanities in Medicine, 5 (9). Recuperado 08 de febrero del 2013, de http://www.peh-med.com/content/5/1/9
Luft, B. [et al.]. (1996). Azitromycin compared with amoxicillin in the treatment of eritema migrans: a double blind randomized controlled trial. Ann Intern Med, 124, 785-791.
Mayne, P. (2012). Investigation of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue. Clinical, Cosmetic and Investigational Dermatology, 5, 69–78.
Ogden, N., Lindsay, L., Morshed, M., Sockett, P. & Artsobb, H. (2009). The emergence of Lyme disease in Canada. Canadian Medical Association Journal, 180 (12).
Radolf, J., Caimano, M, Stevenson, B. & Hu, L. (2012). Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat. Rev. Microbiol., 10 (2), 87-99.
Sperling, J., Middelveen, M. & Klein, D. (2012). Evolving Perspectives on Lyme Borreliosis in Canada. [Versión electrónica], Open Neurol J, 6, (Suppl 1) 94-103. Recuperado el 6 de febrero de 2013, de http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3474999/
Stricker, R. & Johnson, L. (2011). Lyme disease: the next decade. Infection and Drug Resistance, 11 (4), 1–9.
Villalobos Z., M & Somogyi, T. (2012). Enfermedad de Lyme aguda en Costa Rica: descripción del primer caso autóctono. Acta Méd Costarric., 54 (1): 55-58.
Wormser, G., [et al.]. (2006). The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clin Infect Dis, 43 (9), 1089–134. Recuperado el 13 de febrero de 2013 de, http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-
Patient_Care/PDF_Library/Lyme%20Disease.pdf